2023 News

Kyowa Hakko Bio Co., Ltd. (Kyowa Hakko Bio) & Kyowa Hakko USA, Inc (Kyowa), a subsidiary of Kirin Holdings Company, Limited (Kirin Holdings), is thrilled to announce the celebration of the grand opening of its expanded citicoline manufacturing facilities at the Kyowa Hakko Bio Yamaguchi Production Center, situated in Hofu City, Yamaguchi Prefecture, Japan.

RYSE Supplements, in collaboration with Kyowa Hakko, has announced the launch of 16 newly reformulated SKUs featuring the premium ingredient Cognizin® Citicoline.

Kyowa Hakko USA is proud to commemorate the 20th anniversary of their groundbreaking branded ingredient, Cognizin®.

Kyowa Hakko USA is thrilled to announce that our groundbreaking product, IMMUSE™ postbiotic for immune health, has been honored as the inaugural recipient of the the Ingredient of the Year: Microbiome Modulation category in the esteemed annual awards by NutraIngredients-USA.

Launch Hydrate™ recently announced their game-changing sports drinks featuring Cognizin® Citicoline. With a unique blend of electrolytes and essential vitamins and minerals, athletes will be able to hydrate quickly, focus better and recover faster.

Nectr Energy recently launched their Nectr Nootropics mouth pouches featuring Cognizin® Citicoline. Focused on the energy pouch sector, the brand decided to introduce this innovative delivery system coupled with a key ingredient that was backed by research.

Kyowa Hakko’s IMMUSE™, a research-backed postbiotic, provides immune support for travelers in this new innovative formula, “Well Traveled Immune Activator.

Kyowa Hakko’s Cognizin®, a research-backed nootropic, provides brain health support in this new First-of-its-Kind formula, delivered in a simple single-serve sachet

Kyowa Hakko USA is excited to announce the launch of CENTR Enhanced sparkling water, a functional beverage with a blend of nootropic and adaptogenic ingredients that includes its Cognizin® citicoline.